Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 4/2021

01-08-2021 | Contraception | Research Article

Postpartum contraceptive planning of women with substance abuse disorders

Authors: Christine E. Gilmartin, Oran Milman, Laura Leung

Published in: International Journal of Clinical Pharmacy | Issue 4/2021

Login to get access

Abstract

Background

Women with substance abuse disorders have lower use of contraception. Unplanned pregnancies increase risk of fetal exposure to addictive and teratogenic substances. Postpartum inpatient periods for these women can be challenging times to facilitate contraception planning.

Objective

To explore postnatal contraceptive planning practices, patient preferences for contraception, and supply challenges, and to identify how clinical pharmacists may best provide care in this context.

Setting

A tertiary maternity referral hospital in metropolitan Victoria, Australia (January 2015—December 2018).

Method

A retrospective cohort study was conducted on postnatal women with substance abuse disorders. Patients were excluded if they had delivered at another health service, had inadequate documented evidence of a substance abuse disorder, or had incomplete or unavailable medical records. Records were reviewed for demographic data, admission details, and documented contraceptive planning.

Main outcome measures

Documented contraceptive planning, patient contraception preferences and identified supply challenges.

Results

Ninety-three women were included. Seventy-one (76.3%) had psychiatric disorders or impairments, and 92 (98.9%) had identifiable follow-up challenges (eg. Homelessness). Nine (9.7%) self-discharged/absconded. Eighty-seven (93.5%) had documented postnatal contraception discussions. Sixty-two of 87 (71.3%) considered a medicine/device, three (3.4%) preferred condoms, 10 (11.5%) considered sterilisation, 2 (2.3%) preferred no contraception, and 16 (18.4%) undecided. Etonogestral 68 mg implants were most commonly prescribed (28 of 42; 66.7%).

Conclusion

Inpatient postpartum periods for this cohort were characterised by psycho-social complexities, inconsistent contraceptive planning documentation, and patients seemingly unprepared to consider contraception. This study highlights a need for an earlier decision-making process and pragmatic counselling with antenatal pharmacists.
Literature
5.
go back to reference Popova S, Lange S, Probst C, Gmel G, Rehm J. Estimation of national, regional, and global prevalence of alcohol use during pregnancy and fetal alcohol syndrome: a systematic review and meta-analysis. Lancet Global health. 2017;5:e290–9.CrossRef Popova S, Lange S, Probst C, Gmel G, Rehm J. Estimation of national, regional, and global prevalence of alcohol use during pregnancy and fetal alcohol syndrome: a systematic review and meta-analysis. Lancet Global health. 2017;5:e290–9.CrossRef
6.
go back to reference Connery HS, Albright BB, Rodolico JM. Adolescent substance use and unplanned pregnancy: strategies for risk reduction. Obstet Gynecol Clin North Am. 2014;41(2):191–203.CrossRef Connery HS, Albright BB, Rodolico JM. Adolescent substance use and unplanned pregnancy: strategies for risk reduction. Obstet Gynecol Clin North Am. 2014;41(2):191–203.CrossRef
7.
go back to reference Olsen A, Banwell C, Madden A. Contraception, punishment and women who use drugs. BMC Womens Health. 2014;9(14):5.CrossRef Olsen A, Banwell C, Madden A. Contraception, punishment and women who use drugs. BMC Womens Health. 2014;9(14):5.CrossRef
8.
go back to reference Lundsberg LS, Peglow S, Qasba N, Yonkers KA, Gariepy AM. Is Preconception Substance Use Associated With Unplanned or Poorly Timed Pregnancy? J Addict Med. 2018;12:321–8.CrossRef Lundsberg LS, Peglow S, Qasba N, Yonkers KA, Gariepy AM. Is Preconception Substance Use Associated With Unplanned or Poorly Timed Pregnancy? J Addict Med. 2018;12:321–8.CrossRef
9.
go back to reference Terplan M, Hand DJ, Hutchinson M, Salisbury-Afshar E, Heil SH. Contraceptive use and method choice among women with opioid and other substance use disorders: A systematic review. Prev Med. 2015;80:23–31.CrossRef Terplan M, Hand DJ, Hutchinson M, Salisbury-Afshar E, Heil SH. Contraceptive use and method choice among women with opioid and other substance use disorders: A systematic review. Prev Med. 2015;80:23–31.CrossRef
10.
go back to reference Black KI, Stephens C, Haber PS, Lintzeris N. Unplanned pregnancy and contraceptive use in women attending drug treatment services. Aust N Z J Obstet Gynaecol. 2012;52(2):146–50.CrossRef Black KI, Stephens C, Haber PS, Lintzeris N. Unplanned pregnancy and contraceptive use in women attending drug treatment services. Aust N Z J Obstet Gynaecol. 2012;52(2):146–50.CrossRef
11.
go back to reference Louw KA. Substance use in pregnancy: The medical challenge. Obstet Med. 2018;11:54–66.CrossRef Louw KA. Substance use in pregnancy: The medical challenge. Obstet Med. 2018;11:54–66.CrossRef
12.
go back to reference Hetea A, Cosconel C, Stanescu AAM, Simionescu AA. Alcohol and Psychoactive Drugs in Pregnancy. Maedica. 2019;14:397–401.PubMedPubMedCentral Hetea A, Cosconel C, Stanescu AAM, Simionescu AA. Alcohol and Psychoactive Drugs in Pregnancy. Maedica. 2019;14:397–401.PubMedPubMedCentral
13.
go back to reference Day CA, White B, Reid SE, Fowler M, Black KI. Integration of a contraception clinic into an opioid treatment setting to improve contraception knowledge, accessibility and uptake: a pilot study. Aust N Z J Pub Health. 2020;44:360–2.CrossRef Day CA, White B, Reid SE, Fowler M, Black KI. Integration of a contraception clinic into an opioid treatment setting to improve contraception knowledge, accessibility and uptake: a pilot study. Aust N Z J Pub Health. 2020;44:360–2.CrossRef
14.
go back to reference Edelman NL, Patel H, Glasper A, Bogen-Johnston L. Understanding barriers to sexual health service access among substance-misusing women on the South East coast of England. J Fam Plann Reprod Health Care. 2013;39(4):258–63.CrossRef Edelman NL, Patel H, Glasper A, Bogen-Johnston L. Understanding barriers to sexual health service access among substance-misusing women on the South East coast of England. J Fam Plann Reprod Health Care. 2013;39(4):258–63.CrossRef
15.
go back to reference Loree AM, Gariepy A, Ruger JP, Yonkers KA. Postpartum Contraceptive use and Rapid Repeat Pregnancy Among Women who use Substances. Subst Misuse. 2018;53(1):162–9.CrossRef Loree AM, Gariepy A, Ruger JP, Yonkers KA. Postpartum Contraceptive use and Rapid Repeat Pregnancy Among Women who use Substances. Subst Misuse. 2018;53(1):162–9.CrossRef
16.
go back to reference Dehlendorf C, Krajewski C, Borrero S. Contraceptive counseling: best practices to ensure quality communication and enable effective contraceptive use. Clin Obstet Gynecol. 2014;57(4):659–73.CrossRef Dehlendorf C, Krajewski C, Borrero S. Contraceptive counseling: best practices to ensure quality communication and enable effective contraceptive use. Clin Obstet Gynecol. 2014;57(4):659–73.CrossRef
17.
go back to reference Holder KLP. Contraception and Breastfeeding. Clin Obstet Gynecol. 2015;58(4):928–35.CrossRef Holder KLP. Contraception and Breastfeeding. Clin Obstet Gynecol. 2015;58(4):928–35.CrossRef
18.
go back to reference Loewenberg WY, Keder LM, Keim SA, Gallo MF. Postpartum intentions on contraception use and method choice among breastfeeding women attending a university hospital in Ohio: a cross-sectional study. Reprod Health. 2017;20;14(1):45 Loewenberg WY, Keder LM, Keim SA, Gallo MF. Postpartum intentions on contraception use and method choice among breastfeeding women attending a university hospital in Ohio: a cross-sectional study. Reprod Health. 2017;20;14(1):45
19.
go back to reference Demirci JR, Bogen DL, Klionsky Y. Breastfeeding and Methadone Therapy: The Maternal Experience. Subst Abus. 2015;36:203–8.CrossRef Demirci JR, Bogen DL, Klionsky Y. Breastfeeding and Methadone Therapy: The Maternal Experience. Subst Abus. 2015;36:203–8.CrossRef
20.
go back to reference Krans EE, Cochran G, Bogen DL. Caring for Opioid-dependent Pregnant Women: Prenatal and Postpartum Care Considerations. Clin Obstet Gynecol. 2015;58:370–9.CrossRef Krans EE, Cochran G, Bogen DL. Caring for Opioid-dependent Pregnant Women: Prenatal and Postpartum Care Considerations. Clin Obstet Gynecol. 2015;58:370–9.CrossRef
21.
go back to reference Tsirigotis K. Gender differentiation of indirect self-destructiveness in drug addicted individuals (indirect self-destructiveness in addicted women and men). Psychiatr Q. 2019;90:371–83.CrossRef Tsirigotis K. Gender differentiation of indirect self-destructiveness in drug addicted individuals (indirect self-destructiveness in addicted women and men). Psychiatr Q. 2019;90:371–83.CrossRef
22.
go back to reference Coe AB, Moczygemba LR, Gatewood SB, Osborn RD, Matzke GR, Goode JV. Medication adherence challenges among patients experiencing homelessness in a behavioral health clinic. Res Soc Adm Pharm. 2015;11:e110–20.CrossRef Coe AB, Moczygemba LR, Gatewood SB, Osborn RD, Matzke GR, Goode JV. Medication adherence challenges among patients experiencing homelessness in a behavioral health clinic. Res Soc Adm Pharm. 2015;11:e110–20.CrossRef
24.
go back to reference Yong TY, Fok JS, Hakendorf P, Ben-Tovim D, Thompson CH, Li JY. Characteristics and outcomes of discharges against medical advice among hospitalised patients. Intern Med J. 2013;43(7):798–802.CrossRef Yong TY, Fok JS, Hakendorf P, Ben-Tovim D, Thompson CH, Li JY. Characteristics and outcomes of discharges against medical advice among hospitalised patients. Intern Med J. 2013;43(7):798–802.CrossRef
Metadata
Title
Postpartum contraceptive planning of women with substance abuse disorders
Authors
Christine E. Gilmartin
Oran Milman
Laura Leung
Publication date
01-08-2021
Publisher
Springer International Publishing
Published in
International Journal of Clinical Pharmacy / Issue 4/2021
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-020-01209-8

Other articles of this Issue 4/2021

International Journal of Clinical Pharmacy 4/2021 Go to the issue